MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Efficacy of apomorphine subcutaneous injections in patients with levodopa dose failures and morning akinesia

S.H. Isaacson (Boca Raton, FL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Efficacy of long-term treatment with istradefylline and analysis of the expression of A2A receptor protein and post-transcriptional DNA methylation

N. Kanzato, K. Nakachi, T. Naka, M. Higa, S. Mochizuki, Y. Miyamae (Okinawa Prefecture, Haebaru-cho, Japan)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Efficiency of carotid endarterectomy in vascular parkinsonism in patients with stenotic carotid artery disease

M. Ataniyazov, G. Rakhimbaeva, K. Ataniyazova (Tashkent, Uzbekistan)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Eight weeks of home-based balance training not as effective as therapist-based during dual tasks

E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Electromyographic and kinematic patterns in runner’s dystonia

O.F. Ahmad, P. Ghosh, C. Lungu, B. Karp, C. Stanley, K. Alter (Bethesda, MD, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Elemental profiles as biomarkers for diagnosis and disease progression of Parkinson’s disease

F. Maass, M. Börger, A. Fischbach, B. Michalke, M. Bähr, I. Zerr, P. Lingor (Göttingen, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Endoscopic-guided injection of botulinum toxin into the longus capitis muscle and into the obliquus superior part of the longus colli muscle in dystonic antecaput

G. Reichel, A. Stenner, H. von Sanden, L. Herrmann, C. Feja, S. Löffler (Zwickau, Germany)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Engrailed enhances dopamine synthesis in healthy dopaminergic neurons

D. Alvarez-Fischer, M. Baaske, F. Vulinovic, J. Fuchs, P. Seibler, A. Rakovic, A. Prochiantz, C. Klein (Lübeck, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Epidemiological and clinical profile of essential blepharospasm and its response to treatment with TBA over a 11-year period

J.R.R. Manoel, U.C. Júnior, D.P. Nones, F.M.B. Germiniani, H.A.G. Teive (Curitiba, Brazil)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Epidemiological investigation of yips among Golfers in Japan

Y. Gon, M. Mihara, S. Kawamura, K. Nakata, D. Kabata, A. Shintani, H. Mochizuki (Suita, Japan)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley